Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (621-630 of 4,678) with videos related to

Pageof 468
Sort By:
Cancer Discovery|September 4, 2014
Bladder cancers respond to EGFR inhibitors
Cancer Discovery|September 4, 2014
CTCs could guide cancer therapy
Cancer Discovery|September 4, 2014
French collaboration to advance data analysis
Cancer Discovery|September 4, 2014
RADical response puts an exceptional responder in CHKmate: a synthetic lethal curative response to DNA-damaging chemotherapy?Guang Peng, Scott E Woodman, Gordon B Mills
Cancer Discovery|September 4, 2014
A HER 1-2 punch: dual EGFR targeting deals resistance a deadly blowDon L Gibbons, Lauren Averett Byers
Cancer Discovery|September 4, 2014
Tracing the roots of cancer evolutionYanwen Jiang, Olivier Elemento
Cancer Discovery|September 4, 2014
Rilotumumab extends PFS in gastric cancer
Cancer Discovery|September 4, 2014
The ERBB pathway is recurrently mutated in gallbladder carcinoma
Cancer Discovery|September 4, 2014
Mutant IDH1 is an effective immunotherapeutic target for glioma
Cancer Discovery|September 4, 2014
p62 loss reprograms stromal metabolism to promote tumor growth
Pageof 468

Showing results (621-630 of 4,678) with videos related to

Sort By:
Pageof 468
Cancer Discovery|September 4, 2014
Bladder cancers respond to EGFR inhibitors
Cancer Discovery|September 4, 2014
CTCs could guide cancer therapy
Cancer Discovery|September 4, 2014
French collaboration to advance data analysis
Cancer Discovery|September 4, 2014
RADical response puts an exceptional responder in CHKmate: a synthetic lethal curative response to DNA-damaging chemotherapy?Guang Peng, Scott E Woodman, Gordon B Mills
Cancer Discovery|September 4, 2014
A HER 1-2 punch: dual EGFR targeting deals resistance a deadly blowDon L Gibbons, Lauren Averett Byers
Cancer Discovery|September 4, 2014
Tracing the roots of cancer evolutionYanwen Jiang, Olivier Elemento
Cancer Discovery|September 4, 2014
Rilotumumab extends PFS in gastric cancer
Cancer Discovery|September 4, 2014
The ERBB pathway is recurrently mutated in gallbladder carcinoma
Cancer Discovery|September 4, 2014
Mutant IDH1 is an effective immunotherapeutic target for glioma
Cancer Discovery|September 4, 2014
p62 loss reprograms stromal metabolism to promote tumor growth
Pageof 468